The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Clarke David H since year 2005.
The trader's CIK number is 1251818.
At the time of this reporting, Clarke David H is the Former CEO and Director of Innovate Biopharmaceuticals, Inc. .
(stock ticker symbol INNT).
See this page for all insider trading activities at Innovate Biopharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2016-07-13||INNT||Innovate Biopharmaceuticals, Inc.||Buy||15,000||4.50||67,500|
|2018-01-26||INNT||Innovate Biopharmaceuticals, Inc.||Buy||300,000||.35||105,000|
|2017-11-29||INNT||Innovate Biopharmaceuticals, Inc.||Buy||366,159||.45||164,771|
|2017-03-16||INNT||Innovate Biopharmaceuticals, Inc.||Buy||70,000||1.50||105,000|
|2017-06-23||INNT||Innovate Biopharmaceuticals, Inc.||Buy||172,414||.58||100,000|
|2005-09-27||JJZ||Jacuzzi Brands Inc||Buy||50,000||7.33||366,250|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Clarke David H (Former CEO and Director of Innovate Biopharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.